Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO 43204 in Actinic Keratosis
NCT02549339Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Nov 2015
- Primary completion
- Aug 2016
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ingenol disoxate in actinic keratosis (AK), sponsored by LEO Pharma. Started Nov 2015; status: completed.
02
Drugs
ingenol disoxate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02549339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02549339.